n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hazuku, T; Kawano, K; Kodama, Y; Maruyama, R; Miyazaki, Y; Ohtsuka, E; Saburi, M; Sakata, M; Takata, H; Urabe, S; Wada, J | 1 |
1 other study(ies) available for n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate and Diffuse Large B-Cell Lymphoma
Article | Year |
---|---|
[Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon].
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Doxorubicin; Humans; Lymphadenopathy; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Thiotepa; Transplantation, Autologous; Vincristine | 2022 |